Unique Crypto Strategies
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

Unique Crypto Strategies

Politics

FDA chief counsel who defended abortion pill access under Biden resigns two days into job

by March 13, 2025
March 13, 2025
FDA chief counsel who defended abortion pill access under Biden resigns two days into job

The Food and Drug Administration’s (FDA) top lawyer, who was appointed to the position just this week, has resigned, according to a Thursday morning post on X.

‘Hilary K. Perkins has resigned from her position as Chief Counsel of FDA, effectively immediately,’ the FDA’s official X account posted.  

Perkins – a former assistant director under Biden’s Department of Justice (DOJ) in the consumer protection agency – was selected on Tuesday by acting general Sean Keveney in the Department of Health and Human Services (HHS) as part of a ‘reorganization’ effort by the department, according to an HHS news release.

She previously defended abortion pill access in a high-profile case under Biden’s DOJ, and HHS officials were reportedly unhappy with the decision to appoint Perkins but were overruled by White House officials, according to a report from Axios this week.

‘We’ve been able to recruit higher quality personnel to HHS than in any time in its history,’ HHS Secretary Robert F. Kennedy, Jr., said in a statement Tuesday at the announcement of Perkins’ assignment on Tuesday. ‘These are individuals who will return the agency to gold-standard science, evidence-based medicine, and recalibrate its trajectory toward public health rather than industry profiteering.’

Fox News Digital has reached out to HHS and FDA for comment.

This is a breaking story. Check back for updates.

This post appeared first on FOX NEWS
0
FacebookTwitterGoogle +Pinterest
previous post
Opawica Explorations’ Bazooka Project: A Key Potential Asset in Abitibi Gold Rush
next post
White House pulls nomination of David Weldon as CDC director

You may also like

RFK Jr. says Trump White House will get...

House Republicans to go to war with ‘rogue...

Iran’s nuclear capabilities crushed, but regime’s desire for...

Who will Trump pick next for attorney general...

Experts reveal Trump’s next move could be ‘nail...

Trump sends special message to stranded astronauts, jokes...

Nikki Haley responds after Trump says she won’t...

GOP lawmaker touts $19M Trump tariff success story...

Poll: Musk’s favorability among Republicans drops 16 points...

2 Americans released in exchange for Taliban prisoner

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • State Department investigating Rubio AI impersonator who contacted US, foreign officials

    • DOJ lands legal victory as federal judge allows $800M in grants to be clawed back

    • Desperate Gaza doctors cram several babies into one incubator as fuel crisis reaches critical point

    • GREGG JARRETT: CIA report makes it clear Trump was framed

    • Boeing delivers most airplanes since late 2023 after ramping up 737 Max output

    Categories

    • Business (539)
    • Investing (2,660)
    • Politics (4,259)
    • Uncategorized (1)
    • World (2,726)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: uniquecryptostrategies.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 uniquecryptostrategies.com | All Rights Reserved


    Back To Top